Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta‐Analysis
Cancer Reports · 2025
DOI: 10.1002/cnr2.70168 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Reports, 2025. Verfasst von Kais Antonios und 10 weiteren Autor:innen. Beteiligte Einrichtung: Trinity Health Ann Arbor Hospital, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, Gastroesophageal Reflux. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Barrett's esophagus (BE) is the most widely established precursor to esophageal adenocarcinoma (EAC). Despite current screening guidelines, more than 90% of EAC patients lack a previous diagnosis of BE. We performed a systematic review and meta‐analysis to identify the most important risk factors for the development of BE or EAC. Recent Findings PubMed.gov , Ovid Medline, Embase, and Cochrane Library were searched through March 15, 2024. Studies comparing characteristics of patients with endoscopically diagnosed BE or EAC to control groups satisfied our inclusion criteria. Dual extraction provided data for random‐effects meta‐analyses. Sufficient data were extracted from 54 included studies to perform our meta‐analyses. There were five risk factors with significant associations for the development of BE: symptoms of gastroesophageal reflux at least once weekly (OR, 3.56; 95% confidence interval [CI], 2.03–6.25; p = 0.004) tobacco smoking (OR, 1.41; 95% CI, 1.30–1.51; p < 0.001); alcohol use (OR, 1.37; 95% CI, 1.10–1.71; p = 0.008); male gender (OR, 1.36; 95% CI, 1.19–1.57; p < 0.001); and obesity (BMI > 30 kg/m 2 ) (OR, 1.23; 95% CI, 1.09–1.39; p = 0.003). Tobacco smoking was significantly associated with the diagnosis of EAC (OR, 2.15; 95% CI, 1.85–2.43; p < 0.001).
Conclusion
Five risk factors showed significant associations with the development of BE and one with the development of EAC, with over a three‐fold increase in BE for patients with gastroesophageal reflux more than once weekly. These data could prove useful in developing diagnostic paradigms with higher emphasis on patients experiencing more frequent acid reflux.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Trinity Health Ann Arbor Hospital, Ann Arbor, Michigan, USA.
- Internal Medicine, Trinity Health Ann Arbor Hospital, Ypsilanti, Michigan, USA.
- Michigan State University, East Lansing, Michigan, USA.
ORCID-Profile: Richard A Shellenberger
Zitieren
APA
Antonios, K., Aintabi, D., McNally, P., Berinstein, E., Dutta, P., Sampson, N., Wang, S., Carrillo, C. V., Singh, B., Haider, M., & Shellenberger, R. A. (2025). Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta‐Analysis. Cancer Reports. https://doi.org/10.1002/cnr2.70168
Vancouver
Antonios K, Aintabi D, McNally P, Berinstein E, Dutta P, Sampson N, et al. Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta‐Analysis. Cancer Reports. 2025. doi:10.1002/cnr2.70168
BibTeX
@article{Antonios2025,
author = {Antonios, Kais and Aintabi, Daniel and McNally, Patricia and Berinstein, Elliot and Dutta, Priyata and Sampson, Nicholas and Wang, Sichao and Carrillo, Claudia Villarreal and Singh, Brahm and Haider, Marjan and Shellenberger, Richard A},
title = {Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta‐Analysis},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70168}
}
EUVIMED